CYP19A1 and polycystic ovary syndrome: Albeit some unavoidable limitations, rodent PCOS models based upon the disruption of the light/dark cycle provide a valuable alternative to models based on pharmacological interventions (androgen/estrogen administration, CYP19A1 inhibition), namely by avoiding off-target effects of hormone inducers [36,37].